BCR and B-cell chronic lymphocytic leukemia: Similarly, deletion or expression of hyperactive Lyn in a transgenic mouse model of CLL, despite a clear impact on BCR signaling, failed to establish a connection between the kinase and disease progression (27, 28), highlighting the notion that the multifactorial nature of the disease renders difficult the association of pathophysiology with single molecules within signaling pathways.